The rs2304256 Polymorphism in TYK2 Gene Is Associated with Protection for Type 1 Diabetes Mellitus.

Autor: Pellenz FM; Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Department of Internal Medicine, Graduate Program in Medical Sciences: Endocrinology, Federal University of Rio Grande do Sul, Faculty of Medicine, Porto Alegre, Brazil., Dieter C; Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Department of Internal Medicine, Graduate Program in Medical Sciences: Endocrinology, Federal University of Rio Grande do Sul, Faculty of Medicine, Porto Alegre, Brazil., Duarte GCK; Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Department of Internal Medicine, Graduate Program in Medical Sciences: Endocrinology, Federal University of Rio Grande do Sul, Faculty of Medicine, Porto Alegre, Brazil., Canani LH; Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Department of Internal Medicine, Graduate Program in Medical Sciences: Endocrinology, Federal University of Rio Grande do Sul, Faculty of Medicine, Porto Alegre, Brazil., de Souza BM; Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Department of Internal Medicine, Graduate Program in Medical Sciences: Endocrinology, Federal University of Rio Grande do Sul, Faculty of Medicine, Porto Alegre, Brazil., Crispim D; Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Department of Internal Medicine, Graduate Program in Medical Sciences: Endocrinology, Federal University of Rio Grande do Sul, Faculty of Medicine, Porto Alegre, Brazil.
Jazyk: angličtina
Zdroj: Diabetes & metabolism journal [Diabetes Metab J] 2021 Nov; Vol. 45 (6), pp. 899-908. Date of Electronic Publication: 2021 May 24.
DOI: 10.4093/dmj.2020.0194
Abstrakt: Background: Tyrosine kinase 2 (TYK2) is a candidate gene for type 1 diabetes mellitus (T1DM) since it plays an important role in regulating apoptotic and pro-inflammatory pathways in pancreatic β-cells through modulation of the type I interferon signaling pathway. The rs2304256 single nucleotide polymorphism (SNP) in TYK2 gene has been associated with protection for different autoimmune diseases. However, to date, only two studies have evaluated the association between this SNP and T1DM, with discordant results. This study thus aimed to investigate the association between the TYK2 rs2304256 SNP and T1DM in a Southern Brazilian population.
Methods: This case-control study comprised 478 patients with T1DM and 518 non-diabetic subjects. The rs2304256 (C/A) SNP was genotyped by real-time polymerase chain reaction technique using TaqMan minor groove binder (MGB) probes.
Results: Genotype and allele frequencies of the rs2304256 SNP differed between T1DM patients and non-diabetic subjects (P<0.0001 and P=0.001, respectively). Furthermore, the A allele was associated with protection against T1DM under recessive (odds ratio [OR], 0.482; 95% confidence interval [CI], 0.288 to 0.806) and additive (OR, 0.470; 95% CI, 0.278 to 0.794) inheritance models, adjusting for human leukocyte antigen (HLA) DR/DQ genotypes, gender, and ethnicity.
Conclusion: The A/A genotype of TYK2 rs2304256 SNP is associated with protection against T1DM in a Southern Brazilian population.
Databáze: MEDLINE